BTK and cancer: To characterize the expression of the BTK isoforms in primary tumor tissue, a commercially available head and neck tumor tissue microarray (TMA), containing 48 cases of inflammatory, benign and malignant tumor tissues of the neck, oronasopharynx, larynx and salivary glands, was analyzed.